Abrogation of oral tolerance by feeding encapsulated antigen.
Results from previous studies have indicated that suppression of immune responses cannot be abrogated once oral tolerance has been established. Using a new methodology, OVA was encapsulated and fed to tolerized BDF1 mice. Results from these studies indicated that although IgG2a titers remained low, total IgG and IgG1 antibody titers were no longer suppressed compared to controls. Furthermore, in vitro splenocyte proliferation was not significantly suppressed in tolerized mice fed encapsulated OVA. To determine whether oral tolerance could be abrogated in other strains of mice, BALB/c mice were tolerized and fed encapsulated OVA. Results from these studies indicated that IgG2a as well as IgG1 and total anti-OVA antibody titers were no longer suppressed. Although splenocyte proliferation did remain significantly suppressed in these mice, IFN-gamma and IL-4 levels were no longer decreased. To the best of our knowledge, this is the first time that abrogation of an established oral tolerance has been demonstrated.
Barone
K S
KS
Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, Ohio 45267, USA.
Reilly
M R
MR
Flanagan
M P
MP
Michael
J G
JG
D000180:Acrylic Resins / Q000008:administration & dosage; D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D002214:Capsules; D002645:Chickens; D005260:Female; D007108:Immune Tolerance / Q000276:immunology*; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000097:blood; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D008863:Microspheres; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology*; D011109:Polymethacrylic Acids; D012995:Solubility
D000180:Acrylic Resins; D000941:Antigens; D002214:Capsules; D007074:Immunoglobulin G; D011109:Polymethacrylic Acids; C038300:methylmethacrylate-methacrylic acid copolymer; D010047:Ovalbumin